Home > Dermatology > AAD 2018 > Living in the golden age of psoriasis and atopic dermatitis therapies

Living in the golden age of psoriasis and atopic dermatitis therapies

Expert
Dr Erik Joseph Stratman, Marshfield Clinic, Wisconsin, USA
Conference
AAD 2018
Interview with Dr Erik Joseph Stratmand, Chair of the AAD Scientific Assembly Committee. What are the highlights from AAD 2018? Dr Stratman: “First of all, it is very exciting that we have one of the largest groups of registrants ever, with physicians from every state in the US and over 99 other countries. As for the highlights, we are surely living in the golden age of psoriasis therapies. There is a large number of new psoriasis drugs and as dermatologists want to learn about new therapies, that is certainly one of the hot areas. Furthermore, new therapies for very severe atopic dermatitis (AD) are being discussed. There are also some practice management topics dermatologists have to face; for example, access to drugs...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on